T. Rowe Price Associates’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,933,403
Closed -$118M 3087
2024
Q3
$118M Sell
1,933,403
-38,112
-2% -$2.26M 0.01% 533
2024
Q2
$115M Sell
1,971,515
-170,186
-8% -$8.74M 0.01% 520
2024
Q1
$113M Sell
2,141,701
-1,231,649
-37% -$62M 0.01% 524
2023
Q4
$167M Sell
3,373,350
-447,939
-12% -$20.1M 0.02% 441
2023
Q3
$171M Buy
3,821,289
+103,235
+3% +$4.61M 0.03% 419
2023
Q2
$173M Sell
3,718,054
-20,283
-0.5% -$888K 0.02% 417
2023
Q1
$163M Sell
3,738,337
-804,043
-18% -$39.8M 0.02% 414
2022
Q4
$227M Sell
4,542,380
-1,843,724
-29% -$87.7M 0.04% 354
2022
Q3
$269M Sell
6,386,104
-4,084,650
-39% -$197M 0.04% 314
2022
Q2
$459M Sell
10,470,754
-927,303
-8% -$46M 0.06% 308
2022
Q1
$672M Buy
11,398,057
+335,238
+3% +$19.4M 0.07% 279
2021
Q4
$660M Buy
11,062,819
+1,241,967
+13% +$77.8M 0.06% 300
2021
Q3
$668M Buy
9,820,852
+3,045,355
+45% +$210M 0.06% 298
2021
Q2
$485M Buy
6,775,497
+249,209
+4% +$18.3M 0.04% 343
2021
Q1
$441M Sell
6,526,288
-148,182
-2% -$10.1M 0.04% 361
2020
Q4
$463M Sell
6,674,470
-576,226
-8% -$39.4M 0.05% 336
2020
Q3
$457M Buy
7,250,696
+107,616
+2% +$6.61M 0.05% 315
2020
Q2
$400M Buy
7,143,080
+218,017
+3% +$11.4M 0.05% 327
2020
Q1
$336M Sell
6,925,063
-78,483
-1% -$4.62M 0.05% 323
2019
Q4
$447M Sell
7,003,546
-654,068
-9% -$38.7M 0.06% 321
2019
Q3
$390M Sell
7,657,614
-1,535,833
-17% -$71.5M 0.06% 322
2019
Q2
$439M Sell
9,193,447
-1,642,193
-15% -$83.5M 0.06% 301
2019
Q1
$590M Buy
10,835,640
+2,046,013
+23% +$92.6M 0.09% 230
2018
Q4
$322M Buy
8,789,627
+2,022,400
+30% +$94.9M 0.05% 317
2018
Q3
$397M Buy
6,767,227
+528,775
+8% +$33.8M 0.06% 316
2018
Q2
$407M Sell
6,238,452
-1,279,854
-17% -$79.6M 0.06% 299
2018
Q1
$440M Sell
7,518,306
-942,887
-11% -$63.8M 0.07% 282
2017
Q4
$575M Buy
8,461,193
+1,075,854
+15% +$73M 0.09% 230
2017
Q3
$529M Buy
7,385,339
+1,555,178
+27% +$114M 0.09% 239
2017
Q2
$445M Buy
5,830,161
+929,280
+19% +$76.4M 0.08% 266
2017
Q1
$406M Sell
4,900,881
-1,910,424
-28% -$153M 0.08% 273
2016
Q4
$525M Buy
6,811,305
+516,772
+8% +$39M 0.1% 222
2016
Q3
$504M Buy
6,294,533
+6,096,128
+3,073% +$551M 0.1% 231
2016
Q2
$20.7M Sell
198,405
-2,400
-1% -$257K ﹤0.01% 1088
2016
Q1
$25.3M Buy
200,805
+5,800
+3% +$676K 0.01% 1005
2015
Q4
$23.5M Buy
195,005
+2,700
+1% +$344K ﹤0.01% 1036
2015
Q3
$26.8M Buy
192,305
+100
+0.1% +$13.9K 0.01% 989
2015
Q2
$25.7M Buy
192,205
+10,090
+6% +$1.38M 0.01% 1063
2015
Q1
$25.6M Sell
182,115
-24,100
-12% -$3.25M 0.01% 1051
2014
Q4
$27M Sell
206,215
-20,390
-9% -$2.57M 0.01% 1042
2014
Q3
$26.4M Sell
226,605
-8,010
-3% -$946K 0.01% 1042
2014
Q2
$27.8M Sell
234,615
-733,220
-76% -$83.9M 0.01% 1029
2014
Q1
$110M Sell
967,835
-113,020
-10% -$13.1M 0.02% 605
2013
Q4
$126M Sell
1,080,855
-199,680
-16% -$23.3M 0.03% 550
2013
Q3
$148M Sell
1,280,535
-48,560
-4% -$5.6M 0.04% 478
2013
Q2
$147M Buy
+1,329,095
New +$144M 0.04% 466

Other funds holding SRCL

T. Rowe Price Associates's SRCL Position: Q4 2024 in Review

T. Rowe Price Associates sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 1,933,403 shares — an estimated $118M sold.

T. Rowe Price Associates first reported a position in SRCL in Q2 2013 and held it in 46 quarters. The position peaked at $672M in Q1 2022. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • T. Rowe Price Associates reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,933,403 Stericycle Inc shares in Q4 2024, an estimated $118M.
  • T. Rowe Price Associates first reported a position in Stericycle Inc in Q2 2013 and held it in 46 quarters.
  • T. Rowe Price Associates's Stericycle Inc position peaked at $672M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.